JP Morgan Chase’s Immunomedics Inc IMMU Stock Holding History

JP Morgan Chase’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-45,000	Closed	-$864K	–	6126
2019 Q1	$864K	Sell	45,000 -46,900	-51%	-$756K	﹤0.01%	3900
2018 Q4	$1.31M	Buy	91,900 +41,900	+84%	+$832K	﹤0.01%	3571
2018 Q3	$1.04M	Buy	+50,000	New	+$1.18M	﹤0.01%	3887
2018 Q1	–	Sell	-201,700	Closed	-$3.26M	–	5731
2017 Q4	$3.26M	Hold	201,700	–	–	﹤0.01%	3011
2017 Q3	$2.77M	Hold	201,700	–	–	﹤0.01%	2965
2017 Q2	$1.78M	Buy	201,700 +76,700	+61%	+$539K	﹤0.01%	3116
2017 Q1	$809K	Hold	125,000	–	–	﹤0.01%	3511
2016 Q4	$459K	Buy	+125,000	New	+$370K	﹤0.01%	3815

JP Morgan Chase's IMMU Position: Q4 2020 in Review

JP Morgan Chase sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,135,108 shares — an estimated $96.8M sold.

JP Morgan Chase first reported a position in IMMU in Q2 2013 and held it in 17 quarters. The position peaked at $96.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

JP Morgan Chase reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
JP Morgan Chase sold 1,135,108 Immunomedics Inc shares in Q4 2020, an estimated $96.8M.
JP Morgan Chase first reported a position in Immunomedics Inc in Q2 2013 and held it in 17 quarters.
JP Morgan Chase's Immunomedics Inc position peaked at $96.8M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.